KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
14.90
+0.50 (3.47%)
At close: Feb 6, 2026, 4:00 PM EST
15.35
+0.45 (3.02%)
After-hours: Feb 6, 2026, 4:56 PM EST
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $753.14 million as of February 6, 2026. Its market cap has increased by 74.18% in one year.
Market Cap
753.14M
Enterprise Value
700.14M
1-Year Change
74.18%
Ranking
Category
Stock Price
$14.90
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $753.14M, an increase of 482.47%. That is a compound annual growth rate of 17.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 753.10M | -7.74% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 772.66M |
| Omeros | 761.47M |
| YD Bio | 756.64M |
| MiMedx Group | 744.95M |
| Bright Minds Biosciences | 735.11M |
| Janux Therapeutics | 732.60M |
| Nektar Therapeutics | 714.40M |
| Arbutus Biopharma | 705.83M |